Apolipoprotein E (apoE) levels in brains from Alzheimer disease patients and controls

Brain Research

Volumn 722, Issue 1-2, 1996, Pages 71-77

  Pirttila T ^a,b   Soininen, H ^c   Heinonen, O ^c   Lehtimaki T ^b   Bogdanovic, N ^d   Paljarvi L ^c   Kosunen, O ^c   Winblad, B ^d   Riekkinen Sr , P ^c   Wisniewski, H M ^a   Mehta, P D ^a  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c KUOPIO UNIVERSITY HOSPITAL   (Finland)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Alzheimer's disease; apolipoprotein E; brain extract; enzyme linked immunosorbent assay

Indexed keywords

APOLIPOPROTEIN E;

AGED; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; BRAIN REGION; CEREBELLUM; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FRONTAL CORTEX; GENOTYPE; HISTOCHEMISTRY; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL;

EID: 0029996631     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(96)00183-7     Document Type: Article

References (38)

1. Boerwinkle, E. and Utermann, G., Simultaneous effects of the apolipoprotein E polymorphism on apolipoprotein E, apolipoprotein B, and cholesterol metabolism, Am. J. Hum. Genet., 42 (1988) 104-112.
2. Carlsson, J., Armstrong, V.W., Reiber, H., Felgenhauer, K. and Seidel, D., Clinical relevance of the quantification of apolipoprotein E in cerebrospinal fluid, Clin. Chim. Acta, 196 (1991) 167-176.
3. Evans, K.C., Berger, E.P., Cho, C.G., Weigraber, K.H. and Lansbury, P.T. Jr., Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: Implications for the pathogenesis and treatment of Alzheimer disease. Proc. Natl. Acad. Sci. USA, 92 (1995) 763-767.
4. Delacourte, A., General and dramatic glial reaction in Alzheimer brains, Neurology, 40 (1990) 33-37.
5. Han, S.H., Hulette, C., Saunders, A.M., Einstein, G., Pericak-Vance, M., Strittmatter, W.J., Roses, A.D. and Schmechel, D.E., Apolipoprotein E is present in hippocampal neurons without neurofibrillary tangles in Alzheimer's disease and in age-matched controls, Exp. Neurol., 128 (1994) 13-26.
6. Hansen, L.A., Armstrong, D.M. and Terry, D.M., An immunohistochemical quantification of fibrous astrocytes in the aging human cerebral cortex, Neurobiol. Aging, 8 (1987) 1-6.
7. Heinonen, O., Soininen, H., Sorvari, H., Kosunen, O., Paljärvi, L., Koivisto, E. and Riekkinen, P.J. Sr., Loss of synaptophysin-like immunoreactivity in the hippocampal formation is an early phenomenon in Alzheimer's disease, Neuroscience, 64 (1995) 375-384.
8. Hixon, J.E. and Vernier, D.T., Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI, J. Lipid Res., 31 (1990) 545-548.
9. Kida, E., Golabek, A.A., Wisniewski, T. and Wisniewski, K.E., Regional differences in apolipoprotein E immunoreactivity in diffuse plaques in Alzheimer's disease brain, Neurosci. Lett, 167 (1994) 73-76.
10. Lehtimäki, T., Moilanen, T., Viikari, J., Åkerblom, H.K., Ehnholm, C., Rönnemaa, T., Marniemi, J., Dahlen, G. and Nikkari, T., Apolipoprotein E phenotypes in Finnish youths; a cross-sectional and six-year follow-up study, J. Lipid Res., 31 (1990) 487-495.
11. Ma, J., Yee, A., Brewer, Jr. B., Das, S. and Potter, H., Amyloid-associated proteins α 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments. Nature, 372 (1994) 92-94.
12. Mahley, R.W., Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology, Science, 240 (1988) 622-630.
13. Maniatis, T., Fritsch, E.F. and Sambrook, J., Molecular Cloning: A Laboratory Manual, Cold Spring Harbor laboratory, Cold Spring Harbor, New York, 1982.
14. McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D. and Stadlan, E.M., Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease, Neurology, 34 (1984) 939-944.
15. Mehta, P.D. and Miller, J.A., Tourtellotte, W.W., Oligoclonal IgG bands in plaques from multiple sclerosis brains, Neurology, 32 (1982) 372-376.
16. Mirra, S.S., Heyman, A., McKeel, D., Sumi, S.M., Crain, B.J., Brownlee, L.M., Vogel, F.S., Hughes, J.P., van Belle, G. and Berg, L., and participating CERAD neuropathologists., The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease, Neurology, 41 (1991) 479-486.
17. Namba, Y., Tomonaga, M., Kawasaki, H., Otomo, E. and Ikeda, K., Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease, Brain Res., 541 (1991) 163-166.
18. Nathan, B.P., Bellosta, S., Sanan, D.A., Weisgraber, K.H., Mahley, R.W. and Pitas, R.E., Differential effects of apolipoprotein E3 and E4 on neuronal growth in vitro, Science, 264 (1994) 850-852.
19. Oyama, F., Shimada, H., Oyama, R. and Ihara, Y., Apolipoprotein E genotype, Alzheimer's pathologies and related gene expression in the aged population, Mol. Brain Res., 29 (1995) 92-98.
20. Pirttilä, T., Mehta, P.D., Lehtimäki, T., Kim, K.S., Sersen, E.A., Frey, H., Nikkari, T. and Wisniewski, H.M., Relationship between apolipoprotein E4 allele and CSF amyloid β-protein in Alzheimer's disease and controls, Neurosci. Res. Commun., 15 (1994) 201-207.
21. Poirier, J., Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease, Trends Neurosci., 17 (1994) 525-530.
22. Poirier, J., Davignon, J., Bouthillier, D., Kogan, S., Bertrand, P. and Gauthier, S., Apolipoprotein E polymorphism and Alzheimer's disease, Lancet, 342 (1993) 697-699.
23. Rebeck, G.W., Reiter, J.S., Strickland, D.K. and Hyman, B.T., Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions, Neuron, 11 (1993) 575-580.
24. Richey, P.L., Siedlak, S.L., Smith, M.A. and Perry, G., Apolipoprotein interaction with neurofibrillary tangles and senile plaques in Alzheimer disease: Implications for disease pathogenesis, Biochem. Biophys. Res. Commun., 208 (1995) 657-663.
25. Saunders, A.M., Strittmatter, W.J., Schmechel, D., St. George-Hyslop, P.H., Pericak-Vance, M.A., Joo, S.H., Rosi, B.L., Gusella, J.F., Crapper-MacLachlan, D.R., Alberts, M.J., Hulette, C., Grain, B., Goldgaber, D. and Roses, A.D., Association of apolipoprotein E allele e4 with late-onset familial and sporadic Alzheimer's disease. Neurology, 43 (1993) 1467-1472.
26. Schmechel, D.E., Saunders, A.M., Strittmatter, W.J., Crain, B.J., Hulette, C.M., Joo, S.H., Pericak-Vance, M.A., Goldgaber, D. and Roses, A.D., Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc. Natl. Acad. Sci. USA, 90 (1993) 9649-9653.
27. Soininen, H., Reinikainen, K.J., Partanen, J., Helkala, E-L., Paljärvi, L. and Riekkinen, P.J., Slowing of electroencephalogram and choline acetyltransferase activity in post mortem frontal cortex in definite Alzheimer's disease, Neuroscience, 49 (1992) 529-535.
28. Strickland, D.K., Ashcom, J.D., Williams, S., Burgess, W.H., Migliorini, M. and Argraves. W.S., Sequence identity between the α 2-macroglobulin receptor and low density lipoprotein receptor-related protein suggests that this molecule is a multifunctional receptor, J. Biol. Chem., 265 (1990) 17401-17404.
29. Strittmatter, W.J., Saunders, A.M., Goedert, M., Weisgraber, K.H., Dong, L.M., Jakes, R., Huang, D.Y., Pericak-Vance, M., Schmechel, D. and Roses, A.D., Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: Implications for Alzheimer disease, Proc. Natl. Acad. Sci. USA, 91 (1994) 11183-11186.
30. Strittmatter, W.J., Weisgraber. K.H., Goedert, M., Saunders, A.M., Huang, D., Corder, E.H., Dong, L.M., Jakes, L.M., Jakes, R., Alberts, M.J., Gilbert, J.R., Han, S.H., Hulette, C., Einstein, G., Schmechel, D.E., Pericak-Vance, M.A. and Roses, A.D., Hypothesis: Microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype, Exp. Neurol., 125 (1994) 163-171.
31. Strittmatter, W.J., Weisgraber, K.H., Huang, D.Y., Dong, L.M., Salvesen, G.S. Pericak-Vance, M., Schmechel, D., Saunders, A.M., Goldgaber, D. and Roses, A.D., Binding of human apolipoprotein E to synthetic amyloid β peptide: Isoform-specific effects and implications for late-onset Alzheimer disease, Proc. Natl. Acad. Sci. USA, 90 (1993) 8098-8102.
32. Tsukamoto, K., Watanabe, T., Matsushima, T., Kinoshita, M., Kato, H., Hashimoto, Y., Kurokawa, K. and Teramoto, T., Determination by PCR-RFLP of apoE genotype in a Japanese population, J. Lab. Clin. Med., 121 (1993) 598-602.
33. Vandenplas, S., Grobler-Rabie, A., Brebner, K., Ricketts, M., Wallis, G., Bester, A., Boyd, C. and Matthew, C., Blot hybridization of genomic DNA, J. Med. Genet., 21 (1984) 164-172.
34. van Duijn, C.M., de Knijff, P., Cruts, M., Wehnert, A., Havekes, L.M., Hofman, A. and Van Broeckhoven, C., Apolipoprotein E4 allele in a-population-based study of early-onset Alzheimer's disease. Nature Genet., 7 (1994) 74-77.
35. Wisniewski, T. and Frangione, B., Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid, Neurosri. Lett., 135 (1992) 235-238.
36. Wisniewski, T., Castano, E.M., Golabek, A., Vogel, T. and Frangione, B., Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro. Am. J. Pathol., 145 (1994) 1030-1035.
37. Yamada, T., Kondo, A., Takamatsu, J., Tateishi, J. and Goto, I., Apolipoprotein E mRNA in the brains of patients with Alzheimer's disease, J. Neurol. Sci., 129 (1995) 56-61.
38. Yamaguchi, H., Ishiguro, K., Sugihara, S., Nakazato, Y., Kawarabayashi, T., Sun, X. and Hirai, S., Presence of apolipoprotein E on extracellular neurofibrillary tangles and on meningeal blood vessels precedes the Alzheimer-β-amyloid deposition, Acta Neuropathol., 88 (1994) 413-419.